Clinical • Enrollment closed • Trial completion date • Trial primary completion date
|
HLA-A (Major Histocompatibility Complex, Class I, A) • CTAG1B (Cancer/testis antigen 1B)
|
Proleukin (aldesleukin) • CMB305 • ID-LV305 • cyclophosphamide intravenous